Home

Je me plains Stock lièvre china medical system holdings limited Aspirer Adaptation Détective

China Medical System Holdings Ltd | LinkedIn
China Medical System Holdings Ltd | LinkedIn

China Medical System Holdings Limited - Crunchbase Company Profile & Funding
China Medical System Holdings Limited - Crunchbase Company Profile & Funding

China Medical System Holdings Ltd | LinkedIn
China Medical System Holdings Ltd | LinkedIn

China Medical System Holdings Limited - Crunchbase Company Profile & Funding
China Medical System Holdings Limited - Crunchbase Company Profile & Funding

China Medical System (CHSYF) Stock Price, News & Analysis
China Medical System (CHSYF) Stock Price, News & Analysis

CMS
CMS

China Medical System Holdings Limited annonce une mise à jour volontaire et  commerciale La demande de nouveau médicament pour le méthotrexate  injectable est approuvée en Chine -Le 27 mars 2023 à 01:30 | Zonebourse
China Medical System Holdings Limited annonce une mise à jour volontaire et commerciale La demande de nouveau médicament pour le méthotrexate injectable est approuvée en Chine -Le 27 mars 2023 à 01:30 | Zonebourse

China Medical System received MSCI-ESG “AA” rating again, leading the  industry in ESG management – CMS
China Medical System received MSCI-ESG “AA” rating again, leading the industry in ESG management – CMS

China Medical System Company Profile: Stock Performance & Earnings |  PitchBook
China Medical System Company Profile: Stock Performance & Earnings | PitchBook

CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司 * (Incorporated in the  Cayman Islands with limited liabilit
CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司 * (Incorporated in the Cayman Islands with limited liabilit

Chinese Healthcare Investors - Private Equity, Venture Capital and Family  Office Investor from China
Chinese Healthcare Investors - Private Equity, Venture Capital and Family Office Investor from China

Voluntary and Business Update Announcement The Singapore Manufacturing  Plant Matter and the CDMO Collaboration of an Associate
Voluntary and Business Update Announcement The Singapore Manufacturing Plant Matter and the CDMO Collaboration of an Associate

China Medical System Holdings Limited annuncia un dividendo intermedio per  i sei mesi conclusi il 30 giugno 2023, pagabile il 20 settembre 2023 -28  agosto 2023 alle 15:33 | MarketScreener
China Medical System Holdings Limited annuncia un dividendo intermedio per i sei mesi conclusi il 30 giugno 2023, pagabile il 20 settembre 2023 -28 agosto 2023 alle 15:33 | MarketScreener

Shenzhen Kangzhe, a Subsidiary of China Medical System, Listed in “Shenzhen  Top 500 Enterprises” – CMS
Shenzhen Kangzhe, a Subsidiary of China Medical System, Listed in “Shenzhen Top 500 Enterprises” – CMS

Press release
Press release

China Medical System (867.HK) Armed against Short Selling! The Biggest CSO  Took Control of Full Industrial Chain - The Pharma Times | Pharma & Health  Care News Portal
China Medical System (867.HK) Armed against Short Selling! The Biggest CSO Took Control of Full Industrial Chain - The Pharma Times | Pharma & Health Care News Portal

Shenzhen Kangzhe, a Subsidiary of China Medical System (867.HK), Again  Listed in “Shenzhen Top 500 Enterprises” – CMS
Shenzhen Kangzhe, a Subsidiary of China Medical System (867.HK), Again Listed in “Shenzhen Top 500 Enterprises” – CMS

Baker McKenzie on X: "We represented CytoSorbents Corporation, a leader in  critical care immunotherapy specializing in blood purification, in an  agreement with China Medical System Holdings Limited to bring CytoSorb® to  mainland
Baker McKenzie on X: "We represented CytoSorbents Corporation, a leader in critical care immunotherapy specializing in blood purification, in an agreement with China Medical System Holdings Limited to bring CytoSorb® to mainland

LINA CHAN - Associate (Investment Department) - China Medical System  Holdings Ltd | LinkedIn
LINA CHAN - Associate (Investment Department) - China Medical System Holdings Ltd | LinkedIn

MSCI Upgrades CMS (00867) ESG Rating to 'BBB', Corporate Governance  Performance Exceeds its Global Peers
MSCI Upgrades CMS (00867) ESG Rating to 'BBB', Corporate Governance Performance Exceeds its Global Peers

Chen Chen - Senior Business Development Manager - China Medical System  Holdings Ltd | LinkedIn
Chen Chen - Senior Business Development Manager - China Medical System Holdings Ltd | LinkedIn

CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司 Proposed Exclusive  Agreements in Relation to the Sale and
CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司 Proposed Exclusive Agreements in Relation to the Sale and

China Medical System Holdings Ltd (CHSYF): A Deep Dive into its Upcoming  Dividend
China Medical System Holdings Ltd (CHSYF): A Deep Dive into its Upcoming Dividend

Sun Pharma gives licence to CMS for commercialization of 7 generic products  in China, ET HealthWorld
Sun Pharma gives licence to CMS for commercialization of 7 generic products in China, ET HealthWorld

CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司*
CHINA MEDICAL SYSTEM HOLDINGS LIMITED 康哲藥業控股有限公司*

Sun Pharma, China Medical System Holdings enter into two license agreements  | Zee Business
Sun Pharma, China Medical System Holdings enter into two license agreements | Zee Business

News – CMS
News – CMS